NCT03536390View on ClinicalTrials.gov

A 6-week Study to Evaluate the Safety and Efficacy of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 19, 2018

Primary Completion Date

April 22, 2021

Study Completion Date

April 22, 2021

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Methylphenidate Hydrochloride (HCl) Extended Release Chewable Tablet (ERCT)

Methylphenidate Hydrochloride (HCl) Extended Release Chewable Tablet (ERCT)

DRUG

Placebo

Placebo

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY